Cathelicidin peptide analogues inhibit EV71 infection through blocking viral entry and uncoating
Tingting Fan,Bing Liu,Haoyan Yao,Xinrui Chen,Hang Yang,Shangrui Guo,Bo Wu,Xiaozhen Li,Xinyu Li,Meng Xun,Hongliang Wang
DOI: https://doi.org/10.1371/journal.ppat.1011967
IF: 7.464
2024-01-27
PLoS Pathogens
Abstract:Given the serious neurological complications and deaths associated with enterovirus 71 (EV71) infection, there is an urgent need to develop effective antivirals against this viral infection. In this study, we demonstrated that two Cathelicidin-derived peptides, LL-18 and FF-18 were more potent against EV71 infection than the parent peptide LL-37, which is the mature and processed form of Cathelicidin. These peptides could directly bind to the EV71 virus particles, but not to coxsackievirus, indicative of their high specificity. The binding of peptides with the virus surface occupied the viral canyon region in a way that could block virus-receptor interactions and inhibit viral uncoating. In addition, these peptide analogues could also relieve the deleterious effect of EV71 infection in vivo . Therefore, Cathelicidin-derived peptides might be excellent candidates for further development of antivirals to treat EV71 infection. Enterovirus 71(EV71) is one of the major pathogens that cause hand, foot, and mouth disease, and in some cases severe neurological symptoms. There is currently no approved antiviral for EV71. Here in this study, we demonstrated that two antimicrobial peptides derived from the Cathelicidin family, namely, LL-18 and FF-18 were effective against EV71 infection in vitro and in vivo . These peptides could bind directly to the viral particle surface and prevent the virus from entering the host cell as well as blocking successful viral genome release. In addition, we also showed that LL-18 has a low propensity to induce virus resistance. Therefore, these peptides represent promising candidates for EV71 antivirals.
microbiology,virology,parasitology